Gyn medical oncologist @ Moffitt Cancer Center | Owner/Founder MMarkham Travel. Tweets = my opinions only.
Tampa, Florida
Joined January 2011
- Tweets9.5K
- Following1.7K
- Followers7.3K
- Likes3.8K
This is hope in graph form.
#ASCO26
Presented at #ASCO26:
Among patients with previously treated metastatic pancreatic ductal adenocarcinoma, the RAS(ON) inhibitor daraxonrasib led to significantly longer overall survival and progression-free survival than chemotherapy. Full phase 3 RASolute 302 trial results: nej.md/4nWaxvM
@ASCO
ALT Graph from a study published in the New England Journal of Medicine on daraxonrasib versus chemotherapy for metastatic pancreatic cancer. The x-axis represents months, and the y-axis shows the percentage of patients alive. Two lines indicate survival rates: daraxonrasib (blue) and chemotherapy (gray). The bottom section lists patients at risk over time. Title and journal logo are included.
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
A wonderful session in the WNC where I leave as inspired as a panelist as hopefully our audience did! 💓 to @DrMarkham @DrCrystalD #ASCO26
Such a wonderful panel with @DrSGraff @DrCrystalD, facilitated by Dr. Molly Barry. Take home messages: negotiating one’s career looks different over time; there isn’t just one way to do it; know what’s important to you in your career and in life; know your worth. #ASCO26
A wonderful session in the WNC where I leave as inspired as a panelist as hopefully our audience did! 💓 to @DrMarkham @DrCrystalD #ASCO26
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
🚨New data from #ASCO26 and the RUBY trial suggest more than half of patients with dMMR/MSI-H advanced or recurrent endometrial cancer treated with dostarlimab plus chemotherapy may achieve durable disease control with curative potential.
Moffitt’s Merry Jennifer Markham, MD (@DrMarkham), discusses the follow-up data from @SitemanCenter, @washumedicine and @matthewapowell, highlighting the promising four-year survival outcomes. #MoffittASCO26
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
#ThisIsWho grew up to sit with women on the worst days of their lives, fight for more time, and then train the next generation of doctors to do the same.
She’s at #ASCO26 this week making sure she never stops learning how to do it better.
#ThisIsWhoASCO26 #WomenInOncology #Gyncsm @DrMarkham @ASCO @UFHealthCancer @HemeOncGators
#thiswho didn’t know yet that women with gynecologic cancers would teach her - every single day - what it actually means to live, and that fighting for them would become the greatest privilege of her life. She’s honored to be at #ASCO26 learning how to do it better.
#thisiswhoASCO26
#Gyncsm #womeninoncology @DrMMurphy @MoffittNews @MoffittGYNONC
📍Meet the Expert at #ASCO26
Join Merry Jennifer Markham, MD, at Moffitt's booth (#14012) on Saturday from 10:30–11:30 a.m.
She specializes in gynecologic cancers, with a primary research focus on ovarian cancer. Stop by to learn more about the latest advances in research and care.
#MoffittASCO26
The Art of Oncology series remains my favorite section to read in @JCO_ASCO. Storytelling is what makes us human, and Art of Oncology contains some of the best of it. #ASCO26
Ever wonder how to get an essay or poem into @JCO_ASCO? Join me, @DrSGraff, and Dr. Tim Gilligan at the @ASCO annual meeting on Saturday, May 30 at 1:15 CDT in JCO Central S402A for a candid discussion on what we love and what's meh! @SylvesterCancer @BrownMedicine @CleClinicMD
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
Stop by the #ASCO26 Women’s Networking Center dailynews.ascopubs.org/do/pl…
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
Excited for #ASCO26!!!! Come along with me as I review all the heavy hitting oral and rapid fire abstracts 🔥🔥🔥 for #Gynecologic cancers 🦀 from the 2026 @ASCO Program #gyncsm
#MoffittASCO26 @MoffittNews @MoffittGYNONC
As we gear up for the start of #ASCO26, I want to highlight this clinical notice from @ASCO cautioning against recommending ivermectin or fenbendazole for cancer treatment outside of a clinical trial. There is a lot we don't know. High quality clinical trials are the only way we get there. connection.asco.org/do/asco-…
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
To view GOG’s guide to Gynecologic Oncology at ASCO’s abstracts, posters and GYN Clinical trials, go to ow.ly/Znq550Z5hl1 #GOGF #GOGPartners #GynecologicOncology #ASCO26
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
Ready. Set. ASCO!!!
Excited to kick us off by sharing exciting topics and our own CAR-T advances @A2Bio68125!
#ASCO26 #MoffittASCO26
🚨 New research being presented at #ASCO26 suggest GLP-1 medications may be associated with a lower risk of metastatic progression in several obesity-related cancers.
Moffitt’s Monica Avila, MD (@MAvilaMD), discusses the findings from @ClevelandClinic and what they could mean for future cancer research.
Read more: bit.ly/4eeo4KT
#MoffittASCO26
Okay @ASCO members -- time to nominate those amazing leaders you know and trust.
Recommend a colleague by June 5, 2026, for the upcoming ASCO Election.
Learn more and submit your recommendations: bit.ly/4cKmkYI
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
Cross-specialty 🙌🏼 Collaboration @MoffittNews drives standards 🧮 in #cancercare. Fieldtrip 🚌 to Frozen 🧊 Path Lab w/Dr. Hakam shows how the learner microscope 🔬 teaches premeds 👶🏽, med students 👦🏻 and residents 💁🏻♀️ alike, optimizing #surgery results @MoffittGYNONC real-time ⏱️
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
@DrMarkham speaks with ASCO Connection on working through burnout
Beyond the White Coat: Dr. Merry Jennifer Markham on Embracing Your Identity Outside of Medicine | connection.asco.org/do/beyon…
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
Terrific (&entertaining) piece by @JCO_ASCO Oncology Practice editor @EthicsdoctorP on what he thinks AI could do to transform oncology practice by 2035.
OK Computer! Reflections on How Artificial Intelligence Saved Cancer Care | JCO Oncology Practice ascopubs.org/doi/full/10.120…
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
A big big thank you to our 4 great ASCO LDP mentors, who choose to dedicate an enormous amount of time & energy to this program.
We appreciate all of their support!
@montypal, @DrMarkham, Nasser Hanna & Piyush Srivastava 🙏
The first session of the 2025-2026 @ASCO Leadership Development Program cohort starts today. I’m thrilled to serve as a mentor again this year. It’s inspiring to get to work with such a talented group of participants and mentors - and the ASCO staff of course!
Merry-Jennifer Markham, MD, FACP, FASCO retweeted
💢 #Racism, #misogyny, sexual comments and threats from patients take a toll on #healthcare providers.
Our #HealioExclusive explores how patient incivility is becoming normal, and breaking #physicians down...
@IshwariaMD @StanfordMed @uwsmph @DrMarkham
bit.ly/43VAkMi